ICU Medical Q1 2022 Earnings Report
Key Takeaways
ICU Medical's first quarter 2022 revenue was $543.1 million, a significant increase from $318.0 million in the same period last year, primarily due to the acquisition of Smiths Medical. However, the company reported a GAAP net loss of $(38.1) million, or $(1.61) per diluted share, compared to a net income of $23.7 million, or $1.09 per diluted share, for the first quarter of 2021.
First quarter revenue reached $543.1 million, up from $318.0 million year-over-year.
GAAP gross profit was $168.8 million, compared to $112.7 million in the same period last year.
GAAP net loss was $(38.1) million, or $(1.61) per diluted share, a decrease from net income of $23.7 million, or $1.09 per diluted share, in the first quarter of 2021.
Adjusted diluted earnings per share was $1.82, compared to $1.62 for the first quarter of 2021.
ICU Medical
ICU Medical
ICU Medical Revenue by Segment
Forward Guidance
This press release contains forward-looking statements, and actual results and events could differ materially from those projected due to various risks and uncertainties.
Revenue & Expenses
Visualization of income flow from segment revenue to net income